Zilia, a Quebec, Canada-based ocular health startup, raised $4m in seed funding.
The round was led by Anges Québec, with participation from the Government of Quebec through its new program, Impulsion PME, administered by Investissement Québec as a government agent, and other backers.
The company intends to use the funds to complete the regulatory approval process for the clinical launch of Zilia Ocular, its first product.
Led by Patrick Sauvageau, co-founder and CEO, Zilia is advancing Zilia Ocular, a retinal camera to measure oxygen saturation in the eye. This technology aims to enable early diagnosis and management of many ocular diseases.
The platform technology can be adapted to assess a vast array of biomarkers present in the eye, paving the way for other applications in neurology, cardiology, oncology, and more.
FinSMEs
22/08/2021